NEW YORK (GenomeWeb News) – Metabolon today said that it has completed its acquisition of Lipomics Technologies for an undisclosed amount.

Lipomics' laboratory facilities will remain at the company's headquarters in Sacramento, Calif., while Metabolon will keep its headquarters and laboratories in Research Triangle Park, NC. Steven Watkins, the founder of Lipomics, is joining Metabolon as chief technology officer.

The combined company now has 140 employees and 450 clients.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: researchers classify pancreatic cancer into four subtypes using sequencing, and more.

Genotyping analysis of measles in Ontario indicates the strain there didn't originate from Disneyland or Europe.

The UK Medical Research Council says the proposed path of a new train line could affect research at the Francis Crick Institute.

In Genome Biology this week: miRNAs linked to diffuse large B-cell lymphoma outcomes, database of bird genomes, and more.